These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8153056

  • 1. Effects of remoxipride's metabolites on dopamine D2 receptors and receptor functions in the rat.
    Ogren SO, Hall H, Widman M, Angeby-Möller K.
    Pharmacol Toxicol; 1993 Dec; 73(6):325-34. PubMed ID: 8153056
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat.
    Ogren SO, Lundström J, Nilsson LB, Widman M.
    J Neural Transm Gen Sect; 1993 Dec; 93(3):187-203. PubMed ID: 8217058
    [Abstract] [Full Text] [Related]

  • 3. Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors.
    Mohell N, Sällemark M, Rosqvist S, Malmberg A, Högberg T, Jackson DM.
    Eur J Pharmacol; 1993 Jul 06; 238(1):121-5. PubMed ID: 8405075
    [Abstract] [Full Text] [Related]

  • 4. Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
    Westlind-Danielsson A, Gustafsson K, Andersson I.
    Eur J Pharmacol; 1994 Dec 15; 288(1):89-95. PubMed ID: 7705472
    [Abstract] [Full Text] [Related]

  • 5. Concentrations of remoxipride and its phenolic metabolites in rat brain and plasma. Relationship to extrapyramidal side effects and atypical antipsychotic profile.
    Ogren SO, Lundström J, Nilsson LB.
    J Neural Transm Gen Sect; 1993 Dec 15; 94(3):199-216. PubMed ID: 8123230
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT.
    Homan EJ, Copinga S, Unelius L, Jackson DM, Wikström HV, Grol CJ.
    Bioorg Med Chem; 1999 Jul 15; 7(7):1263-71. PubMed ID: 10465402
    [Abstract] [Full Text] [Related]

  • 9. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.
    Ogren SO, Hall H, Köhler C, Magnusson O, Sjöstrand SE.
    Psychopharmacology (Berl); 1986 Jul 15; 90(3):287-94. PubMed ID: 2947255
    [Abstract] [Full Text] [Related]

  • 10. In vivo effects of remoxipride and aromatic ring metabolites in the rat.
    Ahlenius S, Ericson E, Hillegaart V, Nilsson LB, Salmi P, Wijkström A.
    J Pharmacol Exp Ther; 1997 Dec 15; 283(3):1356-66. PubMed ID: 9400011
    [Abstract] [Full Text] [Related]

  • 11. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan 15; 280(1):73-82. PubMed ID: 8996184
    [Abstract] [Full Text] [Related]

  • 12. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G, Demenge P.
    J Cardiovasc Pharmacol; 1991 Oct 15; 18(4):548-55. PubMed ID: 1724532
    [Abstract] [Full Text] [Related]

  • 13. Biochemical pharmacology of the atypical neuroleptic remoxipride.
    Köhler C, Hall H, Magnusson O, Lewander T, Gustafsson K.
    Acta Psychiatr Scand Suppl; 1990 Oct 15; 358():27-36. PubMed ID: 1978484
    [Abstract] [Full Text] [Related]

  • 14. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG, Jadhav SA, Gaikwad RV, Gaonkar RK, Thorat VM, Balsara JJ.
    Indian J Physiol Pharmacol; 2007 Oct 15; 51(4):375-86. PubMed ID: 18476392
    [Abstract] [Full Text] [Related]

  • 15. Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats.
    Kostrzewa RM, Kastin AJ.
    Brain Res Bull; 1993 Oct 15; 31(6):707-12. PubMed ID: 8100182
    [Abstract] [Full Text] [Related]

  • 16. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO, Hall H, Köhler C, Magnusson O, Lindbom LO, Angeby K, Florvall L.
    Eur J Pharmacol; 1984 Jul 20; 102(3-4):459-74. PubMed ID: 6149133
    [Abstract] [Full Text] [Related]

  • 17. Ontogeny of apomorphine-induced stereotypy and its D1 and D2 receptor mediation in rats depleted of dopamine as neonates.
    Abrams DR, Bruno JP.
    Dev Psychobiol; 1992 Nov 20; 25(7):475-95. PubMed ID: 1459343
    [Abstract] [Full Text] [Related]

  • 18. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
    Andersson K, Fuxe K, Eneroth P, Härfstrand A, Agnati LF.
    Neuroendocrinology; 1988 Aug 20; 48(2):188-200. PubMed ID: 2975769
    [Abstract] [Full Text] [Related]

  • 19. Independent mediation of unconditioned motor behavior by striatal D1 and D2 receptors in rats depleted of dopamine as neonates.
    Bruno JP, Byrnes EM, Johnson BJ.
    Psychopharmacology (Berl); 1995 Nov 20; 122(1):85-94. PubMed ID: 8711069
    [Abstract] [Full Text] [Related]

  • 20. Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors.
    Zhu MY, Juorio AV, Paterson IA, Boulton AA.
    Eur J Pharmacol; 1993 Jul 20; 238(2-3):157-64. PubMed ID: 8104805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.